Clinical Trial Update: Screening Trial of Nivolumab With Image Guided, Stereotactic Body Radiotherapy (SBRT) Versus Nivolumab Alone in Patients With Metastatic Head and Neck Squamous Cell Carcinoma (HNSCC) [Phase 2]

View source ↗

Summary

Phase 2 trial comparing nivolumab with image-guided SBRT versus nivolumab alone in metastatic head and neck squamous cell carcinoma has been completed with resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Head and Neck Squamous Cell Carcinoma (HNSCC) | Phase 2 | Status: COMPLETED | Results posted: 2022-03-10